• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Role of Genetic versus Genomic Testing in Cancer

Video

“Genetic testing is really about the patient, and it is helpful to find out what is the patient’s risk” to a particular disease explained Edmund Pezalla, MD, MPH. He thinks that research in this field—prediction of an individual’s risk for a particular type of cancer such as breast or prostate or colon cancer— is currently in its early stages.

“Genomics, on the other hand is about the tumor itself. The tumor has a different genetic makeup than the patient, and it might actually have a different genetic makeup subsequent to treatment. So a tumor further down the treatment road may be different from where it started,” said Dr Pezalla.

“So genomics is important in that it specifically tells us about the tumor that the patient has and it helps us guide treatment, while genetics is about the patient and it helps us guide screening and other preventive services,” he explained.


Related Videos
Will Shapiro
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Screenshot of Raajit Rampal, MD, PhD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.